Abstract
COVID-19 caused devastating effects of human loss and suffering along with disruption in clinical research, forcing reconceptualization and modification of studies. This paper attempts to outline the steps followed and detail the modifications undertaken to deal with the impacts of the pandemic on the first ongoing randomized controlled trial on effectiveness of neuropsychological rehabilitation in adult patients with drug-resistant epilepsy in India. All modifications were based on evolving guidelines and circumstantial context and were planned, reviewed and approved by important stakeholders. Results obtained from the trial need to be interpreted and analysed within this context. These modifications have implications for wider outreach of neuropsychology services in India.
【저자키워드】 Randomized controlled trials, Tele-neuropsychology, WHOWorld Health Organization, World Health Organization, RCTsrandomized controlled trials, Drug resistant epilepsy, NIHNational Institutes of Health, National Institutes of Health, TMTTraditional Memory Training, Traditional Memory Training, LBTLumosity Brain Training, Lumosity Brain Training, BSWPBiostatistics Working Party, Biostatistics Working Party, INSInternational Neuropsychological Society, International Neuropsychological Society, ILAEInternational League Against Epilepsy, International League Against Epilepsy, CTRIClinical Trials Registry of India, Clinical Trials Registry of India, DREDrug Resistant Epilepsy, FGDsFocus Group Discussions, Focus Group Discussions, TeleNPTele-Neuropsychology, HIPPAHealth Insurance Portability and Accountability Act, Health Insurance Portability and Accountability Act, 【초록키워드】 COVID-19, Randomized controlled trial, pandemic, Trial, India, rehabilitation, epilepsy, Impact, Research, Patient, Effectiveness, Modification, Effect, implication, Result, caused, approved, analysed, drug-resistant, 【제목키워드】 COVID-19, rehabilitation, Controlled trial,